Advertisement
Screener

ZURA BIO LIMITED (ZURA) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

2.1 / 5 stars · 10/24 Roast Me

ZURA BIO LIMITED Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

ZURA BIO LIMITED (ZURA) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $2.47 million as of 2025-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-19

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.47M.
  • 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.99M.
  • 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $831.00K.
Period endDeferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
2025-12-31$2.47M
10-K · filed 2026-03-19
2024-12-31$1.99M
10-K · filed 2026-03-19
2023-12-31$831.00K
10-K · filed 2025-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Surrozen, Inc./DE (SRZN)United States$0.395B
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
AGENUS INC (AGEN)United States$0.383B1.41
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Eikon Therapeutics, Inc. (EIKN)United States$0.446B